Automox Redefines Endpoint Management with FastAgent for Unmatched Reliability, Speed, and User Control

AUSTIN, TX, Jan. 21, 2025 (GLOBE NEWSWIRE) — Automox, the leader in cloud-native IT operations and endpoint management solutions, launches FastAgent, a breakthrough in modern agent technology designed to deliver unprecedented speed, reliability, and control for IT professionals. With reimagined communication protocols, infrastructure, and user-facing functionality, FastAgent modernizes endpoint management to meet the evolving demands […]

Ivans Index Q4 and Year-End 2024 Results Released

Milwaukee, WI., Jan. 21, 2025 (GLOBE NEWSWIRE) — Ivans(R) today announced the results for Q4 and year-end 2024 Ivans Index(TM), the insurance industry's premium renewal rate index. The fourth quarter results of 2024 showed premium renewal rate change for all major commercial lines of business, except Workers' Compensation, are up year over year. Compared to

MKS Instruments Showcases Customer-Focused Photonics Innovations at SPIE’s Photonics West 2025

(NASDAQ:MKSI), MKS' signature brands – Newport(TM), Ophir(R), and Spectra-Physics(R) – continue commitment to innovation with leading-edge products ANDOVER, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI) (“MKS”), a global provider of enabling technologies that transform our world, is committed to developing, delivering, and scaling innovative, customer-focused products and services for the

Boomerang Announces Acquisition of GQueues

SANTA CLARA, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) — Boomerang, a pioneer in productivity, today announced it has acquired GQueues, the leading task management and workflow organization platform for Google Workspace. Starting today, subscribers to Boomerang's Premium plan will also have access to GQueues for BUSINESS at no additional cost. New GQueues paid subscribers can

Edible Garden to Present at the 2025 Sequire Investor Summit in Puerto Rico, January 21-23, 2025

(NASDAQ:EDBL),(NASDAQ:EDBLW), BELVIDERE, NJ, Jan. 21, 2025 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic, and sustainable produce and products, today announced that it will be presenting at the upcoming Sequire Investor Summit 2025, scheduled for January 21st-23rd, 2025,

2X Makes Strategic Investment in Get Levrg to Expand Scalable Marketing-as-a-Service Solutions

MALVERN, Pa., Jan. 21, 2025 (GLOBE NEWSWIRE) — 2X, the leader in marketing as a service (MaaS), today announced a strategic investment in Get Levrg, a subscription-based service provider delivering tailored go-to-market (GTM) solutions for start-ups, founder-led, and venture-backed businesses. This investment extends 2X's proven enterprise frameworks and tools to smaller organizations, enabling them to

Tive & BioPharma Dive Reveal How Pharma Leaders Combat Rising Supply Chain Risks with Visibility Technology

BOSTON, Jan. 21, 2025 (GLOBE NEWSWIRE) — Tive, the global leader in supply chain and logistics visibility technology, today announced the results of a groundbreaking survey–“How Pharma Supply Chain Leaders are Mitigating Rising Security Risks with Visibility Technology“–conducted in partnership with BioPharma Dive's studioID. More than 100 pharmaceutical, biologics, and medical device manufacturing executives were

FASTEST GROWING BRANDS TO WATCH IN 2025 – RANKINGS RELEASED BY NUMERATOR

CHICAGO, Jan. 21, 2025 (GLOBE NEWSWIRE) — Numerator, a data and tech company serving the market research space, has released its rankings of Brands to Watch in 2025. The list leverages proprietary Numerator consumer data, including survey, psychographics, and purchase metrics, to identify brands expected to experience significant growth in the coming year. A blended

Shuttle Pharma Reaches Milestone in Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

(NASDAQ:SHPH), GAITHERSBURG, Md., Jan. 21, 2025 (GLOBE NEWSWIRE) — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), announced today that it has achieved 25% enrollment in the initial randomized portion of its Phase 2 Clinical

Muscular Dystrophy Association’s Legacy Awards Honor Pioneers in Clinical Research and Community Impact at 2025 MDA Clinical & Scientific Conference in March

New York, Jan. 21, 2025 (GLOBE NEWSWIRE) — The Muscular Dystrophy Association (MDA) is proud to announce that Katherine Mathews, MD, a renowned leader in genetic medicine and pediatric neurology at the University of Iowa, will be honored with the 2025 MDA Legacy Award for Achievement in Clinical Research. Additionally, Donavon Decker, the first muscular

Scroll to Top